Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 2
2013 2
2014 4
2015 6
2016 3
2017 5
2018 5
2019 6
2020 5
2021 11
2022 6
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis.
Rheault MN, Alpers CE, Barratt J, Bieler S, Canetta P, Chae DW, Coppock G, Diva U, Gesualdo L, Heerspink HJL, Inrig JK, Kirsztajn GM, Kohan D, Komers R, Kooienga LA, Lieberman K, Mercer A, Noronha IL, Perkovic V, Radhakrishnan J, Rote W, Rovin B, Tesar V, Trimarchi H, Tumlin J, Wong MG, Trachtman H; DUPRO Steering Committee and DUPLEX Investigators. Rheault MN, et al. N Engl J Med. 2023 Dec 28;389(26):2436-2445. doi: 10.1056/NEJMoa2308550. Epub 2023 Nov 3. N Engl J Med. 2023. PMID: 37921461 Clinical Trial.
Lupus Nephritis Risk Factors and Biomarkers: An Update.
Renaudineau Y, Brooks W, Belliere J. Renaudineau Y, et al. Among authors: belliere j. Int J Mol Sci. 2023 Sep 25;24(19):14526. doi: 10.3390/ijms241914526. Int J Mol Sci. 2023. PMID: 37833974 Free PMC article. Review.
Clinical and Prognostic Factors in Patients with IgG4-Related Kidney Disease.
Chaba A, Devresse A, Audard V, Boffa JJ, Karras A, Cartery C, Deltombe C, Chemouny J, Contamin C, Courivaud C, Duquennoy S, Garcia H, Joly D, Goumri N, Hanouna G, Halimi JM, Plaisier E, Hamidou M, Landron C, Launay D, Lebas C, Legendre M, Masseau A, Mathian A, Mercadal L, Morel N, Mutinelli-Szymanski P, Palat S, Pennaforte JL, Peraldi MN, Pozdzik A, Schleinitz N, Thaunat O, Titeca-Beauport D, Mussini C, Touati S, Prinz E, Faller AL, Richter S, Vilaine E, Ferlicot S, Von-Kotze C, Belliere J, Olagne J, Mesbah R, Snanoudj R, Nouvier M, Ebbo M, Zaidan M. Chaba A, et al. Among authors: belliere j. Clin J Am Soc Nephrol. 2023 Aug 1;18(8):1031-1040. doi: 10.2215/CJN.0000000000000193. Epub 2023 Jun 7. Clin J Am Soc Nephrol. 2023. PMID: 37283461
Reply to Coussement et al.
Kaminski H, Belliere J, Couzi L, Kamar N, Merville P. Kaminski H, et al. Among authors: belliere j. Clin Infect Dis. 2021 Aug 16;73(4):753-754. doi: 10.1093/cid/ciab022. Clin Infect Dis. 2021. PMID: 33449995 No abstract available.
miRNAs in urine: a mirror image of kidney disease?
Papadopoulos T, Belliere J, Bascands JL, Neau E, Klein J, Schanstra JP. Papadopoulos T, et al. Among authors: belliere j. Expert Rev Mol Diagn. 2015 Mar;15(3):361-74. doi: 10.1586/14737159.2015.1009449. Epub 2015 Feb 8. Expert Rev Mol Diagn. 2015. PMID: 25660955 Review.
Single-cell RNA sequencing identifies senescence as therapeutic target in rhabdomyolysis-induced acute kidney injury.
Rao SN, Zahm M, Casemayou A, Buleon M, Faguer S, Feuillet G, Iacovoni JS, Joffre OP, Gonzalez-Fuentes I, Lhuillier E, Martins F, Riant E, Zakaroff-Girard A, Schanstra JP, Saulnier-Blache JS, Belliere J. Rao SN, et al. Among authors: belliere j. Nephrol Dial Transplant. 2024 Feb 28;39(3):496-509. doi: 10.1093/ndt/gfad199. Nephrol Dial Transplant. 2024. PMID: 37697719
Abcc6 deficiency prevents rhabdomyolysis-induced acute kidney injury.
Casemayou A, Belliere J, Letavernier E, Colliou E, El Hachem H, Zarowski J, Bazin D, Kounde C, Piedrafita A, Feuillet G, Schanstra JP, Faguer S. Casemayou A, et al. Among authors: belliere j. Sci Rep. 2023 Dec 6;13(1):21513. doi: 10.1038/s41598-023-47894-z. Sci Rep. 2023. PMID: 38057332 Free PMC article.
56 results